Abstract
Background
Immune thrombocytopenic purpura (ITP) is a common autoimmune disorder diagnosed with thrombocytopenia and bleeding symptoms due to production of autoantibodies (Abs) against platelets. Nowadays, microRNAs are known as novel biomarkers for diagnosis of diseases. The aim of this study was to investigate the expression levels of miR-21 and miR-150 in ITP patients and determine the role of these miRNAs in ITP pathogenesis.
Materials and Methods
Thirty newly diagnosed patients with acute ITP and 30 healthy subjects( age and sex matched) as controls were enrolled in this study. The expression level of miR-21 and miR-150 was investigated using Real-time-PCR. Comparison of demographic characteristics of the cases was done using independent t-test and chi-square test. Comparison of the expression level of miR-21 and miR-150 with the related parameters was done using independent t-test or Mann–Whitney and Kruskal–Wallis test. Spearman rho correlation coefficient was used to investigate the relationship between the expression of miR-21 and miR-150 with demographic characteristics.
Results
The expression of miR-21, 150 in the patients was not different compared with the control group in general. A significant relationship between the expression of miR-21 with hemoglobin, hematocrit and red blood cell hemoglobin concentration was observed.
Discussion
Expression of miR-21 and miR-150 is not associated with pathogenesis of acute ITP and can involve the synergistic role of other miRNAs. Investigation of miR-21 and miR-150 expression along with other miRNAs and cytokines can be helpful in diagnosis and pathogenesis of ITP.
Similar content being viewed by others
References
Anindo M I, Yaqinuddin A (2012). Insights into the potential use of microRNAs as biomarker in cancer. Int J Surg, 10(9): 443–449
Babashah S, Sadeghizadeh M, Tavirani M R, Farivar S, Soleimani M (2012). Aberrant microRNA expression and its implications in the pathogenesis of leukemias. Cell Oncol (Dordr), 35(5): 317–334
Bai H, Xu R, Cao Z, Wei D, Wang C (2011). Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line. FEBS Lett, 585(2): 402–408
Bay A, Coskun E, Oztuzcu S, Ergun S, Yilmaz F, Aktekin E (2014). Plasma microRNA profiling of pediatric patients with immune thrombocytopenic purpura. Blood Coagul Fibrinolysis, 25(4): 379–383
Bustin S A, Benes V, Garson J A, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl M W, Shipley G L, Vandesompele J, Wittwer C T (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem, 55(4): 611–622
Dai Y, Huang Y S, Tang M, Lv T Y, Hu C X, Tan Y H, Xu ZM, Yin Y B (2007). Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus, 16(12): 939–946
Edelstein L C, Bray P F (2011). MicroRNAs in platelet production and activation. Blood, 117(20): 5289–5296
Edelstein L C, Bray P F (2011). MicroRNAs in platelet production and activation. Blood, 117(20): 5289–5296
Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, Mussolin L, Ruggero K, Bonanno L, Guffanti A, De Bellis G, Gerosa G, Stellin G, D’Agostino D M, Basso G, Bronte V, Indraccolo S, Amadori A, Zanovello P (2011). Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood, 117(26): 7053–7062
Gordon J E, Wong J J, Rasko J E (2013). MicroRNAs in myeloid malignancies. Br J Haematol, 162(2): 162–176
Heyns Adu P, Badenhorst P N, Lötter M G, Pieters H, Wessels P, Kotzé H F (1986). Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ. Blood, 67(1): 86–92
Hussein K, Theophile K, Büsche G, Schlegelberger B, Göhring G, Kreipe H, Bock O (2010). Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome. Leuk Res, 34(3): 328–334
Jernås M, Nookaew I, Wadenvik H, Olsson B (2013). MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP). Blood, 121(11): 2095–2098
Johnsen J(2012). Pathogenesis in immune thrombocytopenia: new insights. Hematology Am Soc Hematol Educ Program, 2012(1): 306–312
Khodadi E, Asnafi A A, Shahrabi S, Shahjahani M, Saki N (2016). Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis. Ann Hematol, 95(11): 1765–1776
Ku F C, Tsai C R, Der Wang J, Wang C H, Chang T K, Hwang W L (2013). Stromal-derived factor-1 gene variations in pediatric patients with primary immune thrombocytopenia. Eur J Haematol, 90(1): 25–30
Li H, Zhao H, Wang D, Yang R (2011). microRNA regulation in megakaryocytopoiesis. Br J Haematol, 155(3): 298–307
Machlus K R, Thon J N, Italiano J E Jr(2014). Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation. Br J Haematol, 165(2): 227–236
Naderi M, Abdul T H, Soleimani M, Shabani I, Hashemi S M (2015). A Home-brew Real-time PCR Assay for Reliable Detection and Quantification of Mature miR-122. Appl Immunohistochem Mol Morphol, 23(8): 601–606
Pfaffl M W, Horgan G W, Dempfle L (2002). Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res, 30(9): e36
Rank A, Weigert O, Ostermann H (2010). Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle. Biologics, 4: 139–145
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold D M, Bussel J B, Cines D B, Chong B H, Cooper N, Godeau B, Lechner K, Mazzucconi M G, McMillan R, Sanz M A, Imbach P, Blanchette V, Kühne T, Ruggeri M, George J N (2009). Standardization of terminology, definitions and outcome criteria in immune thrombo-cytopenic purpura of adults and children: report from an international working group. Blood, 113(11): 2386–2393
Rossi S, Shimizu M, Barbarotto E, Nicoloso MS, Dimitri F, Sampath D, Fabbri M, Lerner S, Barron L L, Rassenti L Z, Jiang L, Xiao L, Hu J, Secchiero P, Zauli G, Volinia S, Negrini M, Wierda W, Kipps T J, Plunkett W, Coombes K R, Abruzzo L V, Keating M J, Calin G A (2010). microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood, 116(6): 945–952
Saki N, Abroun S, Soleimani M, Mortazavi Y, Kaviani S, Arefian E (2014). The roles of miR-146a in the differentiation of Jurkat Tlymphoblasts. Hematology, 19(3): 141–147
Shah P P, Hutchinson L E, Kakar S S (2009). Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer. J Ovarian Res, 2(1): 11
Stasi R (2012). Immune thrombocytopenia: Pathophysiologic and clinical update. Semin Thromb Hemost, 38: 454–462
Tavakoli F, Jaseb K, Jalali Far M A, Soleimani M, Khodadi E, Saki N (2016). Evaluation of MicroRNA-146a expression in acute lymphoblastic Leukemia. Front Biol, 22: 1–6
Wang M, Tan L P, Dijkstra M K, van Lom K, Robertus J L, Harms G, Blokzijl T, Kooistra K, van T’veer M B, Rosati S, Visser L, Jongen-Lavrencic M, Kluin P M, van den Berg A (2008). miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol, 215(1): 13–20
Zhou B, Zhao H, Yang R C, Han Z C (2005). Multi-dysfunctional pathophysiology in ITP. Crit Rev Oncol Hematol, 54(2): 107–116
Zhu C, Wang Y, Kuai W, Sun X, Chen H, Hong Z (2013). Prognostic value of miR-29a expression in pediatric acute myeloid leukemia. Clin Biochem, 46(1-2): 49–53
Acknowledgements
This paper is issued from thesis of Elahe Khodadi, MSc student of hematology and blood banking. This work was financially supported by grant TH94/1 from vice chancellor for research affairs of Ahvaz Jundishapur University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khodadi, E., Asnafi, A.A., Mohammadi-Asl, J. et al. Evaluation of miR-21 and miR-150 expression in immune thrombocytopenic purpura pathogenesis: a case-control study. Front. Biol. 12, 361–369 (2017). https://doi.org/10.1007/s11515-017-1466-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11515-017-1466-y